Home › Heart Failure › Louisiana
Heart Failure clinical trials in Louisiana
20 studies for Heart Failure are looking for participants at sites in Louisiana.
Cities in Louisiana
- New Orleans8 studies
- Houma8 studies
- Monroe5 studies
- Hammond5 studies
- Baton Rouge5 studies
- Shreveport4 studies
- Lafayette3 studies
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Bossier City
- Research Site, Covington
- Research Site, Lafayette
- and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- University Medical Center New Orleans, New Orleans
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 24, 2026 · NCT06736574A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Grace Research, LLC-Bossier City-51040, Bossier City
- Heart Clinic of Hammond, Hammond
- Grace Research, LLC-Shreveport-64616, Shreveport
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06424288A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Heart Clinic of Hammond, Hammond
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06935370Alleviant ALLAY-HFrEF Study
- Cardiovascular Institute of the South, Houma
- University Medical Center New Orleans, New Orleans
Recruiting
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT06812533Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Our Lady of the Lake Medical Center, Baton Rouge
- Louisiana Heart Center - Hammond, Covington
- Heart Clinic of Hammond, Hammond
- and 1 more
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 16, 2026 · NCT07037459Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Alexandria
- Research Site, Bossier City
- Research Site, Shreveport
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Sep 15, 2026 · NCT06677060Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, West Monroe
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Sep 11, 2026 · NCT06307652A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Baton Rouge, LA Investigative Site 10030, Baton Rouge
- Hammond, LA Investigative Site 10106, Hammond
- West Monroe, LA Investigative Site 10090, West Monroe
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06008197A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- CON-10030 Baton Rouge, LA Investigational Site, Baton Rouge
- CON-10090, West Monroe, LA, West Monroe
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06024746A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
- Local Institution - 155, Houma
RecruitingPhase 2
Ages 30 to 84 · All sexes · Updated Aug 31, 2026 · NCT07795814LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
- Tenax Investigational Site, New Orleans
- Tenax Investigational Site, West Monroe
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Aug 19, 2026 · NCT07288398A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Cardiovascular Institute of the South, Houma
Recruiting
Ages 18 to 85 · All sexes · Updated Aug 18, 2026 · NCT07214376A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Grace Research, LLC, Bossier City
- Horizon Research Group of Opelousas, LLC, Eunice
- Cardiovascular Institute of the South, Houma
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07567001Alleviant ALLAY-HF Study
- Cardiovascular Institute of the South, Houma
- University Medical Center New Orleans, New Orleans
Recruiting
Ages 40 and older · All sexes · Updated Aug 14, 2026 · NCT05685303ELEVATE-HFpEF Clinical Study
- Cardiovascular Institute of the South, Houma
Recruiting
Ages 40 and older · All sexes · Updated Aug 3, 2026 · NCT06678841A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- FIN-10030, Baton Rouge, LA, Baton Rouge
- FIN-10106, Hammond, LA, Hammond
- FIN-10090, West Monroe, LA, West Monroe
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT06033950The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Cardiovascular Institute South, Houma
- Ochsner Health System, New Orleans
Recruiting
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT03142152Health Electronic Assessment of Risks and Trends Using Biometric Equipment and Technology
- East Jefferson General Hospital, New Orleans
- Tulane University Medical Group Clinics, New Orleans
- University Medical Center, New Orleans
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 120 · All sexes · Updated Mar 5, 2026 · NCT06753045AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
- Cardiovascular Institute of the South, Houma
- Cardiovascular Institute of the South, Lafayette
- University Medical Center New Orleans, New Orleans
RecruitingObservational study
Ages 22 and older · All sexes · Updated Mar 26, 2025 · NCT06378632From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.